BBDDL2059 structure
|
Common Name | BBDDL2059 | ||
|---|---|---|---|---|
| CAS Number | 2691174-27-1 | Molecular Weight | 512.66 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C27H36N4O4S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of BBDDL2059BBDDL2059 is a selective covalent inhibitor of histone methyltransferase EZH2 with an IC50 of 1.5 nM for EZH2-Y641F. BBDDL2059 inhibits lymphoma cell growth at nanomolar concentrations and can be used for anticancer research[1]. |
| Name | BBDDL2059 |
|---|
| Description | BBDDL2059 is a selective covalent inhibitor of histone methyltransferase EZH2 with an IC50 of 1.5 nM for EZH2-Y641F. BBDDL2059 inhibits lymphoma cell growth at nanomolar concentrations and can be used for anticancer research[1]. |
|---|---|
| Related Catalog | |
| Target |
EZH2 Y641F mutant type:1.5 nM (IC50) |
| References |
| Molecular Formula | C27H36N4O4S |
|---|---|
| Molecular Weight | 512.66 |